MCM
SNY icon

Mainstay Capital Management’s Sanofi SNY Stock Holding History

Mainstay Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-315
Closed -$13K – 454
2018
Q2 		$13K Buy
+315
New +$12.4K 0.01% 306

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Mainstay Capital Management's SNY Position: Q3 2018 in Review

Mainstay Capital Management sold out of Sanofi (SNY) in Q3 2018, closing a stake of 315 shares — an estimated $13K sold.

Mainstay Capital Management first reported a position in SNY in Q2 2018 and held it in 1 quarter. The position peaked at $13K in Q2 2018. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

  • Mainstay Capital Management reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
  • Mainstay Capital Management sold 315 Sanofi shares in Q3 2018, an estimated $13K.
  • Mainstay Capital Management first reported a position in Sanofi in Q2 2018 and held it in 1 quarter.
  • Mainstay Capital Management's Sanofi position peaked at $13K in Q2 2018.
  • 480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Mainstay Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.